Ispire Technology Full Year 2025 Earnings: US$0.69 loss per share (vs US$0.27 loss in FY 2024)

Ispire Technology (NASDAQ:ISPR) Full Year 2025 Results

Key Financial Results

• Revenue: US$127.5m (down 16% from FY 2024).
• Net loss: US$39.2m (loss widened by 166% from FY 2024).
• US$0.69 loss per share (further deteriorated from US$0.27 loss in FY 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Europe segment contributing a total revenue of US$74.1m (58% of total revenue). Notably, cost of sales worth US$104.8m amounted to 82% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$52.1m (84% of total expenses). Explore how ISPR's revenue and expenses shape its earnings.

Ispire Technology shares are up 4.8% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 2 warning signs for Ispire Technology (1 is potentially serious!) that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.